申请人:Sterling Winthrop Inc.
公开号:US05453433A1
公开(公告)日:1995-09-26
Compounds of the formula; ##STR1## wherein: Thi is thiadiazolyl or substituted thiadiazolyl; Y is alkylene bridge of 3-9 carbon atoms; R.sub.1 and R.sub.2 are each independently chosen from hydrogen, halo, alkyl, alkenyl, amino, alkylthio, hydroxy, hydroxyalkyl, alkoxyalkyl, alkylthioalkyl, alkylsulfinyl alkyl, alkylsulfonylalkyl, alkoxy, nitro, carboxy, alkoxycarbonyl, dialkylaminoalkyl, alkylaminoalkyl, aminoalkyl, difluoromethyl, trifluoromethyl, or cyano; R.sub.3 is alkoxycarbonyl, phenyl, alkyltetrazolyl, or heterocyclyl; or a pharmaceutically acceptable salt thereof are effective antipicornaviral agents.
该公式化合物的化合物; ## STR1 ##其中:Thi是噻二唑基或取代的噻二唑基;Y是3-9个碳原子的烷基桥;R.sub.1和R.sub.2分别选择自氢、卤素、烷基、烯基、氨基、烷基硫醚、羟基、羟基烷基、烷氧基烷基、烷基硫醚基、烷基磺醚基、烷氧基、硝基、羧基、烷氧羰基、二烷基氨基烷基、烷基氨基烷基、氨基烷基、二氟甲基、三氟甲基或氰基;R.sub.3是烷氧羰基、苯基、烷基四唑基或杂环基;或其在药理学上可接受的盐是有效的抗小RNA病毒药物。